Clinicopathologic features | n | HOXA-AS3 expression | χ2 | P value | |
---|---|---|---|---|---|
Low | High | ||||
Gender | 0.467 | 0.464 | |||
Male | 51 | 27 | 24 | ||
Female | 31 | 14 | 17 | ||
Age (years) | 0.668 | 0.414 | |||
≤ 50 | 17 | 7 | 10 | ||
> 50 | 65 | 34 | 31 | ||
Tumor diameter (cm) | 9.848 | 0.002** | |||
≤ 4 | 48 | 31 | 17 | ||
> 4 | 34 | 10 | 24 | ||
Tumor location | 0.201 | 0.654 | |||
Up + Middle | 34 | 16 | 18 | ||
Down | 48 | 25 | 23 | ||
Tumor differentiation | 2.390 | 0.122 | |||
High + Middle | 41 | 24 | 17 | ||
Low | 41 | 17 | 24 | ||
CEA level (ng/ml) | 3.514 | 0.061 | |||
≤ 5 | 70 | 38 | 32 | ||
> 5 | 12 | 3 | 9 | ||
CA 19-9 level (U/ml) | 1.242 | 0.265 | |||
≤ 37 | 66 | 35 | 31 | ||
> 37 | 16 | 6 | 10 | ||
HP infection | 3.989 | 0.046* | |||
− | 37 | 23 | 14 | ||
+ | 45 | 18 | 27 | ||
T stage | 20.500 | < 0.0001**** | |||
T1-2 | 32 | 26 | 6 | ||
T3-4 | 50 | 15 | 35 | ||
N stage | 25.866 | < 0.0001**** | |||
N0 | 39 | 31 | 8 | ||
N1-3 | 43 | 10 | 33 |